VCM
Versant Capital Management Portfolio holdings
AUM
$797M
1-Year Est. Return
31.82%
This Fund
S&P 500
1 Year Est. Return
+31.82%
AUM
$797M
AUM Growth
+$62.2M
(+8.5%)
Holding
2,760
Top Buys
| 1 | +$9.01M | |
| 2 | +$3.87M | |
| 3 | +$3.86M | |
| 4 |
iShares Gold Trust Micro
IAUM
|
+$2.9M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$2.86M |
Top Sells
| 1 | +$2.4M | |
| 2 | +$1.16M | |
| 3 | +$720K | |
| 4 |
TotalEnergies
TTE
|
+$569K |
| 5 |
Avantis International Equity ETF
AVDE
|
+$541K |
Sector Composition
| 1 | Technology | 13.53% |
| 2 | Financials | 7.62% |
| 3 | Industrials | 5.95% |
| 4 | Consumer Discretionary | 5.81% |
| 5 | Healthcare | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
iShares Core MSCI EAFE ETF
IEFA
$172B
| $550K | 0.07% |
6,145
|
|
||
202
Charles Schwab
SCHW
$170B
| $548K | 0.07% |
5,482
+345
|
|
||
203
TSMC
TSM
$1.84T
| $546K | 0.07% |
1,797
+83
|
|
||
204
Takeda Pharmaceutical
TAK
$56.1B
| $545K | 0.07% |
34,983
+7,913
|
|
||
205
AT&T
T
$203B
| $544K | 0.07% |
21,903
-7,102
|
|
||
206
Gilead Sciences
GILD
$180B
| $542K | 0.07% |
4,417
+182
|
|
||
207
Omega Healthcare
OHI
$13.9B
| $541K | 0.07% |
12,205
+2,900
|
|
||
208
iShares S&P 500 Growth ETF
IVW
$64.2B
| $541K | 0.07% |
4,387
|
|
||
209
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$11B
| $537K | 0.07% |
20,280
-1,196
|
|
||
210
Ingredion
INGR
$7.1B
| $528K | 0.07% |
4,787
+2,330
|
|
||
211
IBM
IBM
$241B
| $524K | 0.07% |
1,768
-841
|
|
||
212
Synchrony
SYF
$24B
| $523K | 0.07% |
6,274
+679
|
|
||
213
AB InBev
BUD
$144B
| $523K | 0.07% |
8,159
+1,281
|
|
||
214
US Foods
USFD
$20.3B
| $515K | 0.06% |
6,831
+1,168
|
|
||
215
Intel
INTC
$230B
| $509K | 0.06% |
13,804
+1,549
|
|
||
216
Sherwin-Williams
SHW
$83.1B
| $509K | 0.06% |
1,570
-581
|
|
||
217
ORIX
IX
$34.5B
| $508K | 0.06% |
17,387
+2,170
|
|
||
218
Boston Scientific
BSX
$108B
| $508K | 0.06% |
5,327
-1,168
|
|
||
219
Fortis
FTS
$29.1B
| $505K | 0.06% |
9,730
+1,323
|
|
||
220
Monolithic Power Systems
MPWR
$52.5B
| $504K | 0.06% |
556
+11
|
|
||
221
Cardinal Health
CAH
$50.8B
| $503K | 0.06% |
2,449
+186
|
|
||
222
Novo Nordisk
NVO
$174B
| $503K | 0.06% |
9,884
+2,845
|
|
||
223
Stryker
SYK
$142B
| $501K | 0.06% |
1,425
+391
|
|
||
224
Qorvo
QRVO
$7.36B
| $497K | 0.06% |
5,883
+1,744
|
|
||
225
Applovin
APP
$172B
| $497K | 0.06% |
737
+36
|
|